Tech Company Financing Transactions

Argos Therapeutics Funding Round

Forbion Capital Partners, Aurora Funds and Intersouth Partners participated in a $25 million Series D funding round for Argos Therapeutics. The funding round was recorded on 4/24/2012.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D

Forbion Capital Partners (Lead Investor) (Sander van Deventer)

Aurora Funds (Jeffrey Clark)

Intersouth Partners (Philip Tracy)

Lumira Capital (Brian Underdown)

Morningside Group

TVM Capital (Hubert Briner)

Proceeds Purpose
The company will use the financing to move its clinical studies forward.

Company Information

Company Status
Mailing Address
4233 Technology Dr.
Durham, NC 27704
Email Address
Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis technology platform.
Argos Therapeutics LinkedIn Company Profile
Social Media
Argos Therapeutics Company Twitter Account
Company News
Argos Therapeutics News
Argos Therapeutics on Facebook
Argos Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Jeffrey Abbey
  Jeffrey Abbey LinkedIn Profile  Jeffrey Abbey Twitter Account  Jeffrey Abbey News  Jeffrey Abbey on Facebook
Chief Financial Officer
Richard Katz
  Richard Katz LinkedIn Profile  Richard Katz Twitter Account  Richard Katz News  Richard Katz on Facebook
Chief Scientific Officer
Charles Nicolette
  Charles Nicolette LinkedIn Profile  Charles Nicolette Twitter Account  Charles Nicolette News  Charles Nicolette on Facebook
VP - Finance
Lori Harrelson
  Lori Harrelson LinkedIn Profile  Lori Harrelson Twitter Account  Lori Harrelson News  Lori Harrelson on Facebook



Browse more venture capital transactions:

Prev: 4/24/2012: FTRANS venture capital transaction
Next: 4/24/2012: Visible Technologies venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary